Journal of Medical Virology

Papers
(The TQCC of Journal of Medical Virology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
The cytokine storm and COVID‐19986
Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation934
Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines596
Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis441
Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes421
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein404
False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence379
Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis351
The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant336
Vaccine hesitancy: Beliefs and barriers associated with COVID‐19 vaccination among Egyptian medical students296
Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis293
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis286
Role of Toll‐like receptors in the pathogenesis of COVID‐19260
A systematic review and meta‐analysis of children with coronavirus disease 2019 (COVID‐19)244
Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective217
Obesity aggravates COVID‐19: A systematic review and meta‐analysis208
Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review204
OMICRON (B.1.1.529): A new SARS‐CoV‐2 variant of concern mounting worldwide fear201
Evaluation of sex‐related hormones and semen characteristics in reproductive‐aged male COVID‐19 patients190
Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review180
Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa177
Coinfection in SARS‐CoV‐2 infected patients: Where are influenza virus and rhinovirus/enterovirus?173
A brief review of influenza virus infection173
Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark163
Chronic COVID syndrome: Need for an appropriate medical terminology for long‐COVID and COVID long‐haulers163
Detection profile of SARS‐CoV‐2 using RT‐PCR in different types of clinical specimens: A systematic review and meta‐analysis162
SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways157
Emerging coronaviruses: Genome structure, replication, and pathogenesis156
Omicron variant (B.1.1.529) of SARS‐CoV‐2, a global urgent public health alert!153
Omicron variant genome evolution and phylogenetics147
A large‐scale meta‐analytic atlas of mental health problems prevalence during the COVID‐19 early pandemic147
Encephalopathy in patients with COVID‐19: A review146
Should RT‐PCR be considered a gold standard in the diagnosis of COVID‐19?141
The epidemiology and clinical characteristics of co‐infection of SARS‐CoV‐2 and influenza viruses in patients during COVID‐19 outbreak132
Vitamin D insufficiency as a potential culprit in critical COVID‐19 patients128
Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K126
Long COVID syndrome‐associated brain fog123
Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID‐19121
Extrapulmonary complications of COVID‐19: A multisystem disease?121
Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessment121
Emergence of Omicron third lineage BA.3 and its importance120
Analysis of 92 deceased patients with COVID‐19119
Droplet digital PCR of viral ‎DNA/RNA, current progress, challenges, and future perspectives117
Anxiety and depression symptoms after virological clearance of COVID‐19: A cross‐sectional study in Milan, Italy112
Multisystem inflammatory syndrome in children related to COVID‐19: A New York City experience110
Long COVID and chronic COVID syndromes108
Safety of COVID‐19 vaccines107
Obesity aggravates COVID‐19: An updated systematic review and meta‐analysis105
Autoimmune complications of COVID‐19105
Expression of the COVID‐19 receptor ACE2 in the human conjunctiva101
Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID‐19 pandemic100
The “post‐COVID” syndrome: How deep is the damage?99
Non‐life‐threatening adverse effects with COVID‐19 mRNA‐1273 vaccine: A randomized, cross‐sectional study on healthcare workers with detailed self‐reported symptoms98
Risk factors prediction, clinical outcomes, and mortality in COVID‐19 patients97
Evolutionary dynamics of SARS‐CoV‐2 nucleocapsid protein and its consequences96
Anemia is associated with severe illness in COVID‐19: A retrospective cohort study94
Bacterial infections and patterns of antibiotic use in patients with COVID‐1994
Increasing host cellular receptor—angiotensin‐converting enzyme 2 expression by coronavirus may facilitate 2019‐nCoV (or SARS‐CoV‐2) infection94
Targeting human TLRs to combat COVID‐19: A solution?92
Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐1991
Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: A systematic review90
Genomic annotation and molecular evolution of monkeypox virus outbreak in 202289
Correlation between a quantitative anti‐SARS‐CoV‐2 IgG ELISA and neutralization activity88
Association between tuberculosis and COVID‐19 severity and mortality: A rapid systematic review and meta‐analysis88
SARS‐CoV‐2 variants and vulnerability at the global level87
The inflammatory markers of multisystem inflammatory syndrome in children (MIS‐C) and adolescents associated with COVID‐19: A meta‐analysis87
Re‐emerging human monkeypox: A major public‐health debacle86
COVID‐19 vaccinations: The unknowns, challenges, and hopes85
Evaluation of seven commercial RT‐PCR kits for COVID‐19 testing in pooled clinical specimens85
Comparative analysis of antiviral efficacy of FDA‐approved drugs against SARS‐CoV‐2 in human lung cells84
Post‐COVID syndrome: A single‐center questionnaire study on 1007 participants recovered from COVID‐1984
High prevalence of SARS‐CoV‐2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran84
Human herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐1983
The outcome of COVID‐19 in patients with hematological malignancy83
Effects of SARS‐CoV‐2 mutations on protein structures and intraviral protein–protein interactions82
Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID‐19 patients82
Alert for non‐respiratory symptoms of coronavirus disease 2019 patients in epidemic period: A case report of familial cluster with three asymptomatic COVID‐19 patients81
Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID‐19 patients80
The global epidemic of SARS‐CoV‐2 variants and their mutational immune escape80
Efficacy of tocilizumab in COVID‐19: A systematic review and meta‐analysis79
The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity79
The first reactive arthritis case associated with COVID‐1978
Cycle threshold values in RT‐PCR to determine dynamics of SARS‐CoV‐2 viral load: An approach to reduce the isolation period for COVID‐19 patients78
Defining IL‐6 levels in healthy individuals: A meta‐analysis77
SARS‐CoV‐2 and SARS‐CoV: Virtual screening of potential inhibitors targeting RNA‐dependent RNA polymerase activity (NSP12)77
Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID‐19 patients: A meta‐regression and decision tree analysis76
Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID‐19: A systematic review and meta‐analysis76
Elevated interleukin‐6 is associated with severity of COVID‐19: A meta‐analysis76
SARS‐CoV‐2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?76
The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: A systematic review and meta‐analysis75
Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review74
Recurrence of positive SARS‐CoV‐2 in patients recovered from COVID‐1974
Risk factors and outcomes of COVID‐19 in New York City; a retrospective cohort study74
Analytical and clinical validation of an ELISA for specific SARS‐CoV‐2 IgG, IgA, and IgM antibodies74
SARS‐CoV‐2 S1 is superior to the RBD as a COVID‐19 subunit vaccine antigen72
RNA‐dependent RNA polymerase of SARS‐CoV‐2 as a therapeutic target72
Epidemiological features and viral shedding in children with SARS‐CoV‐2 infection72
Herpes zoster emergence following mRNA COVID‐19 vaccine72
Impact of COVID‐19 in patients with concurrent co‐infections: A systematic review and meta‐analyses72
Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study71
COVID‐19 vaccines mix‐and‐match: The concept, the efficacy and the doubts71
Vitamin D deficiency is associated with COVID‐19 positivity and severity of the disease71
Genomic and proteomic mutation landscapes of SARS‐CoV‐270
COVID‐19 and coagulation dysfunction in adults: A systematic review and meta‐analysis69
Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis69
Coronapp: A web application to annotate and monitor SARS‐CoV‐2 mutations69
Obesity a predictor of outcomes of COVID‐19 hospitalized patients—A systematic review and meta‐analysis68
Kidney involvement in COVID‐19 and its treatments68
Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis67
Placental SARS‐CoV‐2 in a pregnant woman with mild COVID‐19 disease67
Prolonged SARS‐CoV‐2 RNA detection in anal/rectal swabs and stool specimens in COVID‐19 patients after negative conversion in nasopharyngeal RT‐PCR test67
Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates67
ACE2, TMPRSS2, and Furin variants and SARS‐CoV‐2 infection in Madrid, Spain66
Positive result of Sars‐Cov‐2 in faeces and sputum from discharged patients with COVID‐19 in Yiwu, China66
Monkeypox: A potential global threat?65
Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain‐Barré syndrome and polyneuritis cranialis in COVID‐19 patients: A case series65
HIV/SARS‐CoV‐2 coinfection: A global perspective65
Understanding the pathophysiological changes via untargeted metabolomics in COVID‐19 patients65
Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS‐CoV‐2 infection64
The dynamic changes of serum IgM and IgG against SARS‐CoV‐2 in patients with COVID‐1964
In silico analyses on the comparative sensing of SARS‐CoV‐2 mRNA by the intracellular TLRs of humans64
Characteristics of the first 1119 SARS‐CoV‐2 Omicron variant cases, in Marseille, France, November−December 202164
Molecular evolutionary characteristics of SARS‐CoV‐2 emerging in the United States64
Possible vertical transmission and antibodies against SARS‐CoV‐2 among infants born to mothers with COVID‐19: A living systematic review63
Evaluating the efficiency of specimen pooling for PCR‐based detection of COVID‐1963
Newly diagnosed diabetes mellitus, DKA, and COVID‐19: Causality or coincidence? A report of three cases63
Safety and effectiveness of SARS‐CoV‐2 vaccines: A systematic review and meta‐analysis62
Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID‐1961
Post‐COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross‐sectional evaluation from a community COVID rehabilitatio61
Meta‐analysis of chest CT features of patients with COVID‐19 pneumonia61
Differences in incidence and fatality of COVID‐19 by SARS‐CoV‐2 Omicron variant versus Delta variant in relation to vaccine coverage: A world‐wide review61
Mutational and phylogenetic analyses of the two lineages of the Omicron variant61
Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID‐19: A case study60
Late onset infectious complications and safety of tocilizumab in the management of COVID‐1960
COVID‐19: Herd immunity and convalescent plasma transfer therapy60
In the age of Omicron variant: Paxlovid raises new hopes of COVID‐19 recovery60
The puzzling mutational landscape of the SARS‐2‐variant Omicron60
SARS‐CoV‐2‐specific virulence factors in COVID‐1960
SARS‐CoV‐2 antibodies: IgA correlates with severity of disease in early COVID‐19 infection59
mTOR inhibition in COVID‐19: A commentary and review of efficacy in RNA viruses59
Low serum calcium and phosphorus and their clinical performance in detecting COVID‐19 patients59
Antibody response to SARS‐CoV‐2 vaccination is extremely vivacious in subjects with previous SARS‐CoV‐2 infection59
Risk factors for bacterial infections in patients with moderate to severe COVID‐19: A case‐control study59
Omicron (B.1.1.529 variant of SARS‐CoV‐2); an emerging threat: Current global scenario59
Proportion of asymptomatic infection and nonsevere disease caused by SARS‐CoV‐2 Omicron variant: A systematic review and analysis59
Quantitation of antibodies against SARS‐CoV‐2 spike protein after two doses of CoronaVac in healthcare workers59
Transmission dynamics of SARS‐CoV‐2 within families with children in Greece: A study of 23 clusters58
Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant57
Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy57
The COVID‐19 Yorkshire Rehabilitation Scale (C19‐YRS): Application and psychometric analysis in a post‐COVID‐19 syndrome cohort57
The role of type I interferon in the treatment of COVID‐1956
COVID‐19 in tuberculosis patients: A report of three cases56
Clinical characteristics of COVID‐19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan, China56
Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID‐19 infection55
Duration of SARS‐CoV‐2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID‐1955
Dengue and COVID‐19, overlapping epidemics? An analysis from Colombia54
Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID‐19 cases: A challenging global threat with a special focus on the Indian subcontinent54
Use of chlorhexidine to eradicate oropharyngeal SARS‐CoV‐2 in COVID‐19 patients54
A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS‐CoV‐2 vaccine54
The electrostatic potential of the Omicron variant spike is higher than in Delta and Delta‐plus variants: A hint to higher transmissibility?54
The use of renin–angiotensin–aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID‐19 patients: A systematic review and meta‐analysis53
Antibody responses against SARS‐CoV‐2 in COVID‐19 patients53
Lowering the transmission and spread of human coronavirus53
Viral coinfections in COVID‐1953
Attaching a stigma to the LGBTQI+ community should be avoided during the monkeypox epidemic53
Gastroenterology manifestations and COVID‐19 outcomes: A meta‐analysis of 25,252 cohorts among the first and second waves52
Detection of SARS‐CoV‐2 Omicron (B.1.1.529) variant has created panic among the people across the world: What should we do right now?52
SARS‐CoV‐2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two‐dose CoronaVac vaccine regimen52
Fetal and placental infection with SARS‐CoV‐2 in early pregnancy52
SARS‐CoV‐2 ORF10 antagonizes STING‐dependent interferon activation and autophagy51
COVID‐19 and liver dysfunction: A systematic review and meta‐analysis of retrospective studies51
Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2—A narrative review51
Sex and gender differences in the outcome of patients with COVID‐1951
The clinical characteristics of pediatric inpatients with SARS‐CoV‐2 infection: A meta‐analysis and systematic review51
Could HIV infection alter the clinical course of SARS‐CoV‐2 infection? When less is better51
COVID‐19 related fatigue: Which role for rehabilitation in post‐COVID‐19 patients? A case series51
Co‐infection of influenza A virus and SARS‐CoV‐2: A retrospective cohort study50
Coronavirus genomic nsp14‐ExoN, structure, role, mechanism, and potential application as a drug target50
Rhinovirus spread in children during the COVID‐19 pandemic despite social restrictions—A nationwide register study in Finland50
Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers50
Detection of highly muted coronavirus variant Omicron (B.1.1.529) is triggering the alarm for South Asian countries: Associated risk factors and preventive actions50
Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐1949
Evaluation of antibody response after COVID‐19 vaccination of healthcare workers49
Higher levels of IL‐6 early after tocilizumab distinguish survivors from nonsurvivors in COVID‐19 pneumonia: A possible indication for deeper targeting of IL‐648
Apoptosis‐induced T‐cell lymphopenia is related to COVID‐19 severity48
Antibody response patterns in COVID‐19 patients with different levels of disease severity in Japan47
Performance of a rapid antigen test in the diagnosis of SARS‐CoV‐2 infection47
Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID‐19 patients47
Host factors and vaccine efficacy: Implications for COVID‐19 vaccines47
Effect of mutation and vaccination on spread, severity, and mortality of COVID‐19 disease46
Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection46
Evaluation of sample pooling for diagnosis of COVID‐19 by real time‐PCR: A resource‐saving combat strategy46
Environmental and decontamination issues for human coronaviruses and their potential surrogates45
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID‐19: A rapid review and meta‐analysis45
Association between COVID‐19 and telomere length: A bidirectional Mendelian randomization study45
Questions concerning the proximal origin of SARS‐CoV‐245
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐1945
Role of platelet‐to‐lymphocyte count ratio (PLR), as a prognostic indicator in COVID‐19: A systematic review and meta‐analysis45
Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS‐CoV‐245
Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?45
Stability and transmissibility of SARS‐CoV‐2 in the environment45
A cluster of the new SARS‐CoV‐2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine45
Weak correlation between antibody titers and neutralizing activity in sera from SARS‐CoV‐2 infected subjects45
Melatonin effects on sleep quality and outcomes of COVID‐19 patients: An open‐label, randomized, controlled trial44
Association between red blood cell distribution width and mortality and severity among patients with COVID‐19: A systematic review and meta‐analysis44
Ambient air pollution, meteorology, and COVID‐19 infection in Korea44
Genomic analysis reveals a rapid spread and predominance of lambda (C.37) SARS‐COV‐2 lineage in Peru despite circulation of variants of concern44
Acceptance of COVID‐19 booster vaccination based on the protection motivation theory: A cross‐sectional study in China44
Vaccination versus infection with SARS‐CoV‐2: Establishment of a high avidity IgG response versus incomplete avidity maturation44
SARS‐CoV‐2 infection affects the lower urinary tract and male genital system: A systematic review44
Systemic lupus erythematosus and varicella‐like rash following COVID‐19 in a previously healthy patient43
Clinical outcomes of patients with COVID‐19 and HIV coinfection43
A pilot double‐blind safety and feasibility randomized controlled trial of high‐dose intravenous zinc in hospitalized COVID‐19 patients43
Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS‐CoV‐2)43
The SARS‐CoV‐2 omicron wave is indicating the end of the pandemic phase but the COVID‐19 will continue43
COVID‐19‐associated Guillain‐Barre syndrome: Postinfectious alone or neuroinvasive too?42
Characterization of antibody responses to SARS‐CoV‐2 in convalescent COVID‐19 patients42
Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID42
Culture and identification of a “Deltamicron” SARS‐CoV‐2 in a three cases cluster in southern France42
Reinfection of COVID‐19 after 3 months with a distinct and more aggressive clinical presentation: Case report41
Clinical characteristics and outcomes of COVID‐19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China41
The impact of neutralizing monoclonal antibodies on the outcomes of COVID‐19 outpatients: A systematic review and meta‐analysis of randomized controlled trials41
The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate41
A structural equation model to examine the clinical features of mild‐to‐moderate COVID‐19: A multicenter Italian study41
Convalescent plasma is a clutch at straws in COVID‐19 management! A systematic review and meta‐analysis41
Toward an understanding of regulatory T cells in COVID‐19: A systematic review40
Roles of the polybasic furin cleavage site of spike protein in SARS‐CoV‐2 replication, pathogenesis, and host immune responses and vaccination40
Association between markers of immune response at hospital admission and COVID‐19 disease severity and mortality: A meta‐analysis and meta‐regression40
COVID‐19 multisystem inflammatory syndrome in three teenagers with confirmed SARS‐CoV‐2 infection40
Safety and efficacy of COVID‐19 vaccines in children and adolescents: A systematic review of randomized controlled trials40
Targeting SARS‐CoV‐2 viral proteases as a therapeutic strategy to treat COVID‐1940
The other side of COVID‐19 pandemic: Effects on male fertility40
Prevalence and factors related to COVID‐19 vaccine hesitancy and unwillingness in Canada: A systematic review and meta‐analysis40
Dysregulation of the immune response affects the outcome of critical COVID‐19 patients39
Challenges for management of immune thrombocytopenia during COVID‐19 pandemic39
Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity39
Effect of using a structured pacing protocol on post‐exertional symptom exacerbation and health status in a longitudinal cohort with the post‐COVID‐19 syndrome39
Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID‐1939
Quantitative assessment of SARS‐CoV‐2 RNAemia and outcome in patients with coronavirus disease 201939
Clinical characteristics and predictors of mortality in African‐Americans with COVID‐19 from an inner‐city community teaching hospital in New York39
Could ferritin level be an indicator of COVID‐19 disease mortality?39
Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID‐19 patients38
Evaluation of alpha defensin, IL‐1 receptor antagonist, and IL‐18 levels in COVID‐19 patients with macrophage activation syndrome and acute respiratory distress syndrome38
An update on the origin of SARS‐CoV‐2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O‐linked glycan residues38
Vitamin D and COVID‐19: Role of ACE2, age, gender, and ethnicity38
Are the steroids a blanket solution for COVID‐19? A systematic review and meta‐analysis38
The recombinant variants of SARS‐CoV‐2: Concerns continues amid COVID‐19 pandemic38
Methotrexate inhibits SARS‐CoV‐2 virus replication “in vitro”37
Anti‐SARS‐CoV‐2 IgG levels in relation to disease severity of COVID‐1937
Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge37
0.035193920135498